Skip to main content

Table 1 Patient characteristics

From: A prospective cohort study of outcomes for isoniazid prevention therapy: a nested study from a national QI collaborative in Uganda

Patient characteristicsNumbers (n)Percentages (%)
Age (years)
 < 15566.0
 ≥ 1595494.0
 Total1010100
Gender
 Female62161.4
 Male38938.5
 Total1010100
INH dose (mg/day)
 150566.0
 30095494.0
 Total1010100
HIV status
 Positive1010100
 Negative00
 Total1010100
ART status
 Already on ART10100
 Not on ART00
 Total1010100